Advertisement
Screener

Exelixis Inc (EXEL) ROI

Exelixis Inc (EXEL) ROI

  • 2016-12-31: ROI -25.22%.
  • 2016-09-30: ROI -65.92%.
  • 2016-06-30: ROI -86.30%.
  • 2016-03-31: ROI -81.52%.

Complete source-backed roi history.

Available history
2010-12-31 to 2016-12-31
Data captured

Historical ROI

DateROI
2016-12-31-25.22%
2016-09-30-65.92%
2016-06-30-86.30%
2016-03-31-81.52%
2015-12-31-59.77%
2015-09-30-57.56%
2015-06-30-104.79%
2015-03-31-100.08%
2014-12-31-132.21%
2014-09-30-92.61%
2014-06-30-79.31%
2014-03-31-64.68%
2013-12-31-65.85%
2013-09-30-47.20%
2013-06-30-35.61%
2013-03-31-27.99%
2012-12-31-25.33%
2011-12-3127.81%

Annual ROI

DateROI
2016-12-31-25.22%
2015-12-31-58.36%
2014-12-31-132.21%
2013-12-31-65.85%
2012-12-31-25.33%
2011-12-3127.81%
2010-12-31464.74%

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Twist Bioscience Corp (TWST)United States$11.540B-47.21
BIO-TECHNE Corp (TECH)United States$11.379B74.68
REPLIGEN CORP (RGEN)United States$10.755B185.31
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
Immunovant, Inc. (IMVT)United States$7.028B-14.78